Efficacy and safety of seladelpar in patients with primary biliary cholangitis and alkaline phosphatase levels between 1 and 1.67×upper limit of normal: interim results from the open-label ASSURE study
C Levy, J Heo, M Galambos, P Lutz et autres
0 citationsZeitschrift für Gastroenterologie